newsfilter
← Latest News
GlobeNewswire·

Praxis Precision Medicines to Participate in Upcoming Investor Conferences

  • Praxis Precision Medicines will present at four upcoming investor events in November 2025.
  • The company will deliver a corporate presentation at the Truist Securities BioPharma Symposium on Thursday, November 6, 2025, at 10:40am ET in New York City.
  • A fireside chat with HC Wainwright analyst Doug Tsao is scheduled for Friday, November 7, 2025, at 12:30pm ET during the HC Wainwright Emerging Ideas on BioPharma event.
  • A corporate presentation will occur at the Guggenheim Securities Inaugural Healthcare Innovation Conference on Monday, November 10, 2025, at 9:30am ET in Boston, MA.
  • Praxis will present at the Jefferies Global Healthcare Conference on Tuesday, November 18, 2025, at 1:30pm GMT in London, UK.
  • Replays of the third quarter earnings webinar & conference webcasts will be available on the company's website for approximately 90 days post-event.
  • The company is developing therapies for CNS disorders using its Cerebrum™ small molecule & Solidus™ ASO platforms, with four clinical-stage product candidates.